Q2 2025 · 13F-HR
Bruce & Co., Inc.holdings as filed
Filed 2025-08-14 · accession 0001104659-25-078312
$308.5M
Reported value
41
Positions
2025-06-30
Period end
The Brief · Bruce & Co., Inc. · Q2 2025
AI · grounded in 13F
Bruce & Co., Inc. established a new position in Allstate ALL valued at $25.3M. The fund also initiated new stakes in Uhaul B UHAL/B for $24.6M and Abbvie ABBV for $23.7M. Additional new positions include Nextera Energy for $21.9M and AerCap Holdings AER for $21.5M.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 020002101 | ALL | Allstate | $25.3M | 8.19% | 125,500 | Common | SOLE |
| 023586506 | UHAL/B | Uhaul B | $24.6M | 7.97% | 452,000 | Common | SOLE |
| 00287Y109 | ABBV | Abbvie | $23.7M | 7.67% | 127,500 | Common | SOLE |
| 302571104 | — | Nextera Energy | $21.9M | 7.09% | 315,000 | Common | SOLE |
| N00985106 | AER | AerCap Holdings | $21.5M | 6.96% | 183,500 | Common | SOLE |
| 26441C204 | DUK | Duke Energy | $20.7M | 6.73% | 175,816 | Common | SOLE |
| 00206R102 | T | AT & T | $19.5M | 6.31% | 673,000 | Common | SOLE |
| 002824100 | ABT | Abbott | $18.2M | 5.90% | 133,800 | Common | SOLE |
| 589331107 | — | Merck | $15.3M | 4.95% | 192,800 | Common | SOLE |
| 125896100 | CMS | CMS Energy | $13.6M | 4.40% | 196,000 | Common | SOLE |
| 98389B100 | XEL | XCEL Energy | $13.2M | 4.29% | 194,500 | Common | SOLE |
| 45774W108 | IIIN | Insteel | $12.8M | 4.14% | 343,423 | Common | SOLE |
| 037833100 | AAPL | Apple | $8.0M | 2.59% | 38,900 | Common | SOLE |
| 05379B107 | AVA | Avista | $7.6M | 2.48% | 201,500 | Common | SOLE |
| 717081103 | PFE | Pfizer | $6.6M | 2.14% | 271,900 | Common | SOLE |
| H11356104 | BG | Bunge | $6.4M | 2.08% | 80,000 | Common | SOLE |
| 651639106 | NEM | Newmont | $5.8M | 1.89% | 100,000 | Common | SOLE |
| 039483102 | ADM | Archer Daniels | $5.3M | 1.71% | 100,000 | Common | SOLE |
| 237266101 | DAR | Darling Ingredients | $5.0M | 1.61% | 131,000 | Common | SOLE |
| 023586100 | UHAL | Uhaul | $4.5M | 1.45% | 73,900 | Common | SOLE |
| 925815102 | VICR | Vicor | $4.1M | 1.32% | 90,000 | Common | SOLE |
| 749607107 | RLI | RLI | $2.9M | 0.96% | 40,800 | Common | SOLE |
| 163851108 | CC | Chemours | $2.9M | 0.93% | 250,000 | Common | SOLE |
| 868459108 | SUPN | Supernus | $2.6M | 0.84% | 82,105 | Common | SOLE |
| N53745100 | LYB | Lyondellbasell | $2.3M | 0.75% | 40,000 | Common | SOLE |
| 71535D106 | PSNL | Personalis | $1.7M | 0.54% | 253,000 | Common | SOLE |
| 532457108 | LLY | Eli Lilly | $1.6M | 0.51% | 2,000 | Common | SOLE |
| 92333F101 | VG | Venture Global | $1.6M | 0.51% | 100,000 | Common | SOLE |
| 82968B103 | SIRIEUR | XM Sirius | $1.3M | 0.42% | 55,784 | Common | SOLE |
| 50015M109 | KOD | Kodiak Sciences | $1.2M | 0.39% | 323,000 | Common | SOLE |
| 91911K102 | — | Bausch Health | $1.1M | 0.37% | 171,000 | Common | SOLE |
| 268311107 | EDAP | EDAP | $907,989 | 0.29% | 553,652 | Common | SOLE |
| 044209104 | — | Ashland | $754,200 | 0.24% | 15,000 | Common | SOLE |
| 56400P706 | MNKD | Mannkind | $729,573 | 0.24% | 195,073 | Common | SOLE |
| N51517105 | 4PKB | Lava Theraputics | $688,874 | 0.22% | 521,874 | Common | SOLE |
| 00430HAC6 | AXDX 5 12/15/26 | Accelerate Diagnostic | $658,515 | 0.21% | 3,292,574 | Common | SOLE |
| 92556V106 | VTRS | Viatris | $520,431 | 0.17% | 58,279 | Common | SOLE |
| 65443P102 | MASS | 908 Devices | $486,879 | 0.16% | 68,286 | Common | SOLE |
| 31189P102 | FATE | Fate Theraputics | $480,691 | 0.16% | 429,188 | Common | SOLE |
| 92939U106 | WEC | WEC Energy | $411,069 | 0.13% | 3,945 | Common | SOLE |
| 142038108 | CRBU | Caribou Biosciences | $315,000 | 0.10% | 250,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.